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Electrocardiogram and cardiac testing 
among patients in the emergency 
department with seizure versus syncope
Jennifer L. White1, Judd E. Hollander1, Jesse M. Pines2, Peter M. Mullins2, 
Anna Marie Chang1
1 Department of Emergency Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, 
Philadelphia, PA, USA 
2 Department of Emergency Medicine, The George Washington School of Medicine and Health Sciences, 
Washington, DC, USA
Objective Cardiogenic syncope can present as a seizure. The distinction between seizure disorder 
and cardiogenic syncope can only be made if one considers the diagnosis. Our main objective 
was to identify whether patients presenting with a chief complaint (reason for visit) as seizure 
or syncope received an electrocardiogram in the emergency department across all age groups. 
Methods We conducted a secondary analysis of data collected in the 2010 to 2014 National 
Hospital Ambulatory Medical Care Survey comparing patients presenting with a chief complaint 
of syncope versus seizure to determine likelihood of getting an evaluation for possible life 
threatening cardiovascular disease. The primary endpoint was receiving an electrocardiogram in 
the emergency department; secondary endpoint was receiving cardiac biomarkers. 
Results There was a total of 144,094 patient encounters. Of these visits, 1,553 had syncope and 
1,470 had seizure (60.3% vs. 44.2% female, 19.9% vs. 29.0% non-white). After adjusting for 
age, sex, mode of arrival and insurance, patients with syncope were more likely to receive an 
electrocardiogram compared to patients with seizure (odds ratio, 10.86; 95% confidence interval 
[CI], 8.52 to 13.84). This was true across all age groups (0 to 18 years, 56% vs. 7.5%; 18 to 44 
years, 60% vs. 27%; 45 to 64 years, 82% vs. 41%; ≥65 years, 85% vs. 68%; P<0.01 for all). Car- 
diac biomarkers were also obtained more frequently in adult patients with syncope patients (18 
to 44 years, 17.5% vs. 10.5%; 45 to 64 years, 33.8% vs. 21.4%; ≥65 years, 47.1% vs. 32.3%; 
P<0.01 for all). 
Conclusion Patients evaluated in the emergency department for syncope received an electrocar- 
diogram and cardiac biomarkers more frequently than those that had seizure.
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What is already known
Patients who present with seizure and syncope often overlap and seizure 
may be the first presentation of a malignant arrhythmia syndrome. 
What is new in the current study
Patients presenting to the Emergency Department with seizure do not get 
an electrocardiogram or cardiac biomarkers as frequently as patients who 
present with syncope. 
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INTRODUCTION
Patients presenting with syncope and seizures represent about 4 
percent of all emergency department (ED) visits, amounting to 
over 2 million visits per year.1 Clinical features of syncope and 
seizures often overlap and it is difficult to distinguish the two.2 
Seizures have up to a 30 percent misdiagnosis rate, the most 
common being syncope.3 Recent studies using an implantable 
loop recorder report up to 20% to 30% of patients with seizures 
actually have occult cardiovascular causes.4 Schott et al.5 revealed 
a cardiac cause in 20 percent of patients initially diagnosed with 
epilepsy. 
 An over-diagnosis of seizure disorder can have significant im-
pact on patient lifestyle, resulting in inappropriate medication use 
and driving restrictions. More concerning is that patients with 
cardiac syncope can present with an apparent seizure,2 secondary 
to hypoperfusion. Failure to identify cardiac syncope due to a po-
tentially lethal dysrhythmia would represent a missed opportunity 
to prevent sudden cardiac death.6 
 The purpose of this study is to compare patients with an initial 
complaint of seizure to those with an initial complaint of syncope 
in the ED using a national sample of visits. We hypothesize that 
patients presenting with an initial complaint of seizure are less 
likely to receive an evaluation for cardiac disease than patients 
presenting with an initial complaint of syncope. 
METHODS
Study design and setting
We conducted a secondary analysis of data collected in the 2010 to 
2014 National Hospital Ambulatory Medical Care Survey (NHAMCS) 
comparing patients presenting with an initial complaint (reason 
for visit) of syncope versus seizure to determine likelihood of get-
ting an evaluation for possible life threatening cardiovascular dis-
ease,7 with the primary endpoint being obtaining an electrocar-
diogram (ECG) in the ED. 
 The NHAMCS is an annual, national probability sample of am-
bulatory visits made to non-federal, general, and short-stay hos-
pitals in the US conducted by the Centers for Disease Control and 
Prevention, National Center for Health Statistics. Although the 
survey includes visits to selected ambulatory care departments, 
this analysis focuses solely on the visits to hospital EDs. NHMACS 
data have been utilized previously.8 The NHAMCS is approved an-
nually by the ethics review board of the National Hospital Care 
Survey with waivers of the requirements to obtain informed con-
sent of patients and patient authorization for release of patient 
medical record data by health care providers. 
 Data processing, including medical coding of reason for visit, 
cause of injury, diagnosis, and medications are performed by SRA 
International, Durham, NC, USA. As part of the quality assurance 
procedure, a 10% quality control sample of patient record forms 
is independently keyed and coded. Error rates typically range be-
tween 0.3% and 0.9% for various survey items. 
Subject selection
For this analysis, we included patients that presented in 2010 
through 2014 with one of the five listed reason for visit codes for 
syncope (1,030.0) versus seizure (1,205.0). Patients were excluded 
if they had both codes for syncope and seizure on the same visit. 
Patients were included if they had one of either syncope or sei-
zure or unconsciousness (5,840.0). Patients who left without be-
ing seen, left without treatment complete or signed out against 
medical advice were excluded because the evaluation that would 
have been done had they stayed could not be determined. 
Data collection
From the NHAMCS data collection, we included patient demogra-
phic information including: age, race, sex, insurance type, mode 
of transportation. We included past medical history including sig-
nificant for congestive heart failure, and diagnostic tests includ-
ing complete blood counts (CBC), electrolytes, glucose, lactate, d-
dimer, ECGs, cardiac monitor, computed tomography (CT) head. 
Disposition was also recorded as was final diagnosis of syncope 
International Classification of Diseases (ICD)-9 codes of 780.2, 
780.4, and 276.51 and seizure ICD-9 codes of 780. 39, 345.9, 780.31, 
and 345.4. 
Main outcome
The main outcome was obtaining an ECG. This was chosen as the 
main outcome as it is the best screening test for life threatening 
dysrhythmias or conditions that may make someone prone to a 
life-threatening dysrhythmia, such as long QTc or Brugada syn-
drome, Wolff Parkinson White syndrome, hypertrophic cardiomy-
opathy, arryhthmogenic right ventricular cardiomyopathy, heart 
block or widened QRS. The secondary outcome was obtaining car-
diac biomarkers. 
Statistical analysis
For our primary analysis, we compared test utilization of an ECG 
in patients with seizures versus syncope listed as one of the five 
reasons for visit stratified based upon the age groupings of 0 to 
17, 18 to 44, 45 to 64, and ≥65 years. We chose these groupings 
because the likelihood of identifying cardiovascular and neurolog-
ical disease is not uniform throughout life, and etiology of sei-
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zures and syncope differ in different age groups. We chose the 
age cut off of 45 as patients under the age of 45 are at risk of 
sudden cardiac death due to arryhthmogenic causes that may lie 
quiescent, first presenting as ‘seizure type’ spells. While the pre-
dominant cause of sudden cardiac death in patients older than 45 
is coronary artery disease, the predominant cause of sudden cardi-
ac death in those younger than 45 is hypertrophic cardiomyopa-
thy, followed by myocarditis, and then inherited arryhthmogenic 
syndromes such as long QT syndrome and Brugada syndrome.9
 We performed a similar secondary analysis with cardiac bio-
markers as the outcome. We also compared initial complaint to 
final diagnosis to determine whether syncope or seizure was 
more or less likely to change during the ED evaluation. 
 To determine whether seizure versus syncope patients differed 
by baseline characteristics and outcomes, Student’s t-test and 
Fisher exact test were used for continuous and categorical data, 
respectively. To adjust for possible confounders when examining 
the two groups with regard to final outcome, a forced entry lo-
gistic regression model was used within each age group including 
the following factors: sex, race, past medical history, arrival by 
ambulance and insurance. Odds ratios with 95% confidence in-
tervals (CIs) were calculated for each outcome.
RESULTS
There was a total of 144,094 patient encounters during the study 
period, representing an estimated 668.8 million survey-weighted 
visits. Of these visits, 1,553 (7,279,728 survey-weighted visits) had 
syncope as reason for visit and 1,470 (6,554,859 survey-weighted 
visits) had seizure as one reason for visit. From this overall sam-
ple, 275 visits were excluded due to left without being seen, left 
against medical advice, or being listed with both syncope and 
seizure as reasons for visit, leaving 2,861 visits (13,145,659 sur-
vey-weighted visits) as the study cohort. Overall baseline demo-
graphics are shown in Table 1. 
 The age cohorts (0 to 17, 18 to 44, 45 to 64, and ≥65 years) 
were analyzed separately (Tables 2-5). Across all age groups, pa-
tients with syncope were more likely to receive an ECG (Table 6), 
but the difference decreased with age. After adjusting for age, 
sex, mode of arrival and insurance, patients with syncope were 
more likely to receive an ECG compared to patients with seizure 
(odds ratio, 10.86; 95% CI, 8.52 to 13.84). Patients who were old-
er, non-white, arrived by emergency medical service, and had Medi-
care or private insurance were also more likely to get ECG (Table 7). 
 In all age groups, patients presenting with seizure versus syn-
Table 1. Overall comparison of patients presenting with seizure versus syncope 
Seizure (RFV, %) 95% CI Syncope (RFV, %) 95% CI P-value
Race White 71.0 66.9–74.7 80.1 76.5–83.2 0.001
Non-white 29.0 25.3–33.1 19.9 16.8–23.6
Sex Male 55.8 52.3–59.2 39.7 35.8–43.6 0.001
Female 44.2 40.8–47.7 60.3 56.4–64.2
Comorbidities CHF 3.9 2.8–5.4 0.4 0.2–0.7 a)
Arrival EMS 63.5 59.9–67.0 49.9 45.7–54.0 0.001
Testing CBC 63.1 58.4–67.5 73.1 69.3–76.6 0.001
Electrolytes 29.9 25.8–34.4 35.1 30.4–40.1 0.023
Glucose 39.6 35.5–43.8 45.8 41.3–50.3 0.015
CT head 35.6 32.3–39.1 34.5 30.9–38.3 0.66
Cardiac monitor 15.4 12.7–18.6 28.8 25.3–32.7 0.001
Cardiac enzymes 12.3 9.7–15.5 29.2 25.2–33.5 0.001
Final diagnosis Syncope 3.1 2.1–4.4 64.6 61.4–67.7 0.001
Seizure 45.8 41.7–49.8 1.4 0.8–2.5 0.001
Disposition Admit 16.2 13.7–19.1 23.3 20.3–26.6 0.001
Discharge 83.8 80.9–86.3 76.7 73.4–79.7 0.001
Region Northeast 43.2 37.9–48.7 56.8 51.3–62.1 0.339
Midwest 47.9 42.9–52.9 52.1 47.1–57.1
South 49.6 45.2–54.0 50.4 46.0–54.8
West 45.9 39.9–52.0 54.1 48.0–60.1
Insurance Private insurance 39.0 34.2–44.1 61.0 55.9–65.8 0.001
Medicaid 68.0 62.3–73.2 32.0 26.8–37.7
Medicare 28.5 24.0–33.4 71.5 66.6–76.0
Self pay/other 53.1 46.3–59.8 46.9 40.2–53.7
RFV, reason for visit; CI, confidence interval; CHF, congestive heart failure; EMS, emergency medical service; CBC, complete blood count; CT head, computerized tomogra-
phy of the head.
a)Insufficient sample size to generate reliable estimate per National Center for Health Statistics recommendation.
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cope were more likely to get a CBC (63.1% vs. 73.1%) but not more 
likely to get electrolytes (29.9% vs. 35.1%), or head CT (35.6% vs. 
34.5%). Patients with syncope were more likely to get cardiac 
biomarkers (29.2% vs. 12.3%) compared to patients presenting 
with seizure (Table 1). 
 In the pediatric age group (<18), over 90% of visits resulted in 
a discharge. In adults, 40% were admitted. Arrival by emergency 
medical service had an increased likelihood of getting an ECG 
(Table 7).
 The presenting chief complaint and final diagnosis were less 
Table 2. Comparison of patients presenting with seizure versus syncope, age 0 to 17 years
Seizure (RFV, %) 95% CI Syncope (RFV, %) 95% CI P-value
Race White 71.9 64.8–78.1 81.8 72.9–88.2 0.048
Non-white 28.1 21.9–35.2 18.2 11.8–27.1
Sex Male 63.8 56.7–70.3 47.0 36.1–58.3 0.016
Female 36.2 29.7–43.3 53.0 41.7–64.0
Arrival EMS 55.8 48.6–62.7 29.6 20.9–40.0 0.001
Testing CBC 46.5 38.3–54.8 44.4 34.7–54.4 0.74
Electrolytes 20.0 14.8–26.3 14.3 8.7–22.6 0.201
Glucose 23.9 18.3–30.5 26.6 19.0–35.9 0.607
CT head 18.6 13.7–24.7 21.2 14.6–29.6 0.544
Disposition Discharge 90.8 86.4–93.9 97.6 92.9–99.2 0.012
Region Midwest 62.3 47.4–75.1 37.8 24.9–52.6 0.149
Northeast 57.5 46.3–68.0 42.5 32.1–53.7
South 72.5 63.0–80.4 27.5 19.7–37.1
West 73.4 62.2–82.2 26.6 17.8–37.8
Insurancea) Medicaid 72.6 63.5–80.1 27.4 19.9–36.5 NA
Private insurance 59.6 49.5–69.0 40.4 31.1–50.5 0.055
RFV, reason for visit; CI, confidence interval; EMS, emergency medical service; CBC, complete blood count; CT head, computerized tomography of the head; NA, not appli-
cable due to small sample size.
a)Medicare not applicable in this age group.
Table 3. Comparison of patients presenting with seizure versus syncope, age 18 to 44 years 
Seizure (RFV, %) 95% CI Syncope (RFV, %) 95% CI P-value
Race White 71.8 65.8–77.1 76.7 69.6–82.5 0.289
Non-white 28.2 23.0–34.2 23.3 17.5–30.4
Sex Male 47.7 42.1–53.5 35.4 29.7–41.5 0.004
Female 52.3 46.6–57.9 64.6 58.5–70.3
Arrival EMS 60.0 54.3–65.6 38.2 32.7–44.0 0.001
Testing CBC 66.4 59.7–72.5 64.8 57.2–71.6 0.698
Electrolytes 29.0 23.9–34.8 29.2 23.0–36.4 0.963
Glucose 41.3 35.4–47.4 43.2 36.6–50.0 0.67
CT head 38.1 32.7–43.9 28.9 23.2–35.5 0.04
Cardiac monitor 15.6 11.5–20.7 16.6 12.6–21.7 0.737
Cardiac enzymes 10.5 7.3–14.8 17.5 13.0–23.2 0.012
Disposition Admit 12.3 9.1–16.4 7.3 4.7–11.1 0.042
Discharge 87.7 83.7–90.9 92.7 88.9–95.3 0.042
Region Northeast 52.5 42.5–62.4 47.5 37.7–57.5 0.612
Midwest 55.1 47.8–62.1 45.0 37.9–52.3
South 57.0 50.0–63.8 43.0 6.2–50.0
West 49.7 39.4–60.0 50.3 40.0–60.6
Insurancea) Private insurance 37.1 30.8–43.9 62.9 56.1–69.2 0.001
Medicaid 67.7 59.4–75.1 32.3 24.9–40.6
Self pay/other 53.7 45.4–61.9 46.3 38.1–54.6
RFV, reason for visit; CI, confidence interval; EMS, emergency medical service; CBC, complete blood count; CT head, computerized tomography of the head.
a)Medicare uncommon in this age group.
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Table 4. Comparison of patients presenting with seizure versus syncope, age 45 to 64 years 
Seizure (RFV, %) 95% CI Syncope (RFV, %) 95% CI P-value
Race White 70.2 63.1–76.4 76.5 68.9–82.6 0.207
Non-white 29.8 23.6–36.9 23.5 17.4–31.1
Sex Male 64.3 57.9–70.1 43.0 34.4–52.0 0.001
Female 35.7 29.9–42.1 57.0 48.0–65.6
Arrival EMS 77.1 71.0–82.3 54.2 46.0–62.3 0.001
Testing CBC 68.2 61.0–74.6 83.5 77.8–88.0 0.001
Electrolytes 39.1 31.6–47.1 35.0 27.8–43.1 0.361
Glucose 50.8 43.2–58.4 45.9 37.8–54.2 0.326
CT head 43.6 36.9–50.4 36.1 29.0–43.9 0.148
Cardiac monitor 16.7 12.4–22.1 37.6 29.7–46.2 0.001
Cardiac enzymes 21.4 15.3–29.1 33.8 26.4–42.1 0.012
Disposition Admit 25.2 19.8–31.5 27.0 20.6–34.7 0.672
Discharge 74.8 68.6–80.2 73.0 65.3–79.4
Region Northeast 46.9 35.9–58.2 53.2 41.9–64.1 0.847
Midwest 49.4 37.6–61.2 50.7 38.8–62.4
South 43.1 34.9–51.7 56.9 48.3–65.1
West 46.2 36.6–56.1 53.8 43.9–63.5
Insurancea) Private insurance 32.6 25.5–40.6 67.4 59.4–74.5 0.001
Medicaid 61.7 48.9–73.0 38.3 27.0–51.1
Medicare 51.6 39.3–63.7 48.4 36.3–60.7
Self-pay/other 52.5 39.7–65.0 47.5 35.0–60.3
RFV, reason for visit; CI, confidence interval; EMS, emergency medical service; CBC, complete blood count; CT head, computerized tomography of the head.
a)Medicare uncommon in this age group.
Table 5. Comparison of patients with syncope versus seizure, age greater than 65 years
Seizure (RFV, %) 95% CI Syncope (RFV, %) 95% CI P-value
Race White 64.1 49.6–76.4 86.2 80.5–90.5 0.001
Non-white 35.9 23.7–50.4 13.8 9.5–19.5
Sex Male 46.5 33.5–60.0 38.9 33.8–44.2 0.293
Female 53.5 40.0–66.5 61.1 55.8–66.2
Comorbidities CHF 2.4 0.9–6.5 10.9 7.7–15.2 a)
Arrival EMS 66.1 51.5–78.2 66.4 60.3–72.1 0.963
Testing CBC 88.9 79.9–94.2 83.8 78.1–88.3 0.285
Electrolytes 41.9 29.4–55.6 49.2 42.0–56.5 0.337
Glucose 48.4 35.5–61.6 55.5 49.3–61.6 0.318
CT head 57.6 44.3–69.8 44.0 37.9–50.4 0.072
Cardiac monitor 34.4 23.4–47.3 40.5 34.9–46.4 0.368
Cardiac enzymes 32.3 21.5–45.4 47.1 41.0–53.2 0.027
Final diagnosis Syncope 5.1 2.5–10.1 68.5 62.3–74.0 a)
Seizure 51.7 38.6–64.5 0.4 0.0–2.6
Disposition Admit 38.3 26.3–51.9 45.3 39.5–51.2 0.357
Discharge 61.7 48.1–73.7 54.7 48.8–60.5
Region Northeast 13.8 7.4–24.1 86.3 75.9–92.6 a)
Midwest 15.1 9.4–23.4 84.9 76.6–90.6
South 16.8 11.8–23.5 83.2 76.5–88.2
West 14.8 8.7–23.9 85.2 76.1–91.3
Insurance Private insurance 11.7 4.5–27.3 88.3 72.7–95.5 a)
Medicaid 40.1 8.7–82.4 59.9 17.6–91.3
Medicare 15.0 11.3–19.5 85.1 80.5–88.7
Self-pay/other 16.5 5.0–42.9 83.5 57.1–95.0
RFV, reason for visit; CI, confidence interval; CHF, congestive heart failure; EMS, emergency medical service; CBC, complete blood count; CT head, computerized tomogra-
phy of the head.
a)Insufficient sample size to generate reliable estimate per National Center for Health Statistics recommendation.
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likely to be the same in patients presenting with seizure than synco-
pe, 51.7% (95% CI, 38.6 to 64.5) vs. 68.5% (95% CI, 62.3 to 74.0).
DISCUSSION
Results from this study suggest that patients with an initial com-
plaint of syncope are more likely to get an ECG during their ED 
visit than patients with an initial complaint of seizure; this is true 
in all age groups. Distinguishing between syncope and seizure 
can be challenging to bystanders and providers, but is paramount 
to ensuring a proper work up and treatment. The distinction be-
tween syncope and seizures is often unclear to bystanders. His-
torical features of seizure include prior seizure disorder, tongue 
biting and incontinence. However, patients that have cardiac syn-
cope are often mistaken by witnesses as having seizure like activ-
ity. The fact that NHAMCS does not have specific clinical charac-
teristics often used to distinguish between these two events is a 
limitation; however, these characteristics were likely taken into 
account in assigning a final diagnosis.6
 In this cohort, up to 55% of patients that arrived with an ini-
tial complaint of seizure had an alternative final diagnosis. This is 
consistent with prior studies emphasizing the misdiagnosis of sei-
zure.6 As bystanders are often inaccurate in characterizing the 
event, providers cannot anchor on the presenting complaint, and 
may need to evaluate presumed seizures as a possible arryhthmo-
genic syncopal event. It is notable that the arrival by ambulance, 
irrespective of reason for visit increases that likelihood of a pa-
tient receiving an ECG. 
 Our study demonstrated that the work up for both seizure and 
syncope often included laboratory studies and a head CT; the only 
difference between the groups was in obtaining CBC (seizure 
group) and cardiac enzymes (syncope group). This points out that 
much of the evaluation for an undifferentiated spell (either syn-
cope or seizure) focused on low yield testing unlikely to impact 
detection of life threatening events.10 However, patients with an 
initial complaint of syncope were 10.86 times more likely to get 
an ECG than patients presenting with an initial complaint of sei-
zure across all age ranges. 
 Quinn et al.11 reported predictors of death after ED visit for 
syncope. Patients with an identified cardiac cause had twice the 
rate of death compared to those without syncope and those with 
a neurologic cause had 50% greater risk of death. The Framing-
ham study identified that patients with a vasovagal cause of syn-
cope had a good prognosis whereas those with a cardiac cause of 
syncope had a 10% mortality at 6 months.12 Thus, missing the di-
agnosis of syncope and calling it a seizure can have significant 
downstream effects. The ECG is a simple, non-invasive test that 
has been widely accepted as part of the standard of care evalua-
tion in patients presenting to the ED with syncope, and should be 
strongly considered in patients with seizures.13-15
 The greatest risk lies in the missed arryhthmogenic cause of 
seizure6 because patients with ventricular tachycardia, who could 
easily receive appropriate anti-arrhythmic therapy or implantable 
cardio-defibrillator are instead given anti-epileptics.16 Patients 
with symptomatic bradycardia may miss the opportunity to get a 
pacemaker.17 Inappropriate use of anti-epileptics can have dele-
terious cardiovascular effects, such as carbamazepine induced AV 
block or oxycarbezine induced refractory ventricular fibrillation.18,19
 The limitations of the study are the limitations of using NHAMCS 
as a database. The database is visit based and not population based. 
Therefore, incidence of seizure and syncope cannot be appropri-
ately estimated. In addition, the database does not provide longi-
tudinal data as to patient outcomes and whether these diagnoses 
led to future evaluations. However, the goal of this paper is to 
show the initial bias in evaluations of these two potentially over-
lapping conditions. Another limitation is that the final diagnosis 
is based on abstraction from the chart. While NHAMCS does not 
specify how this was obtained, it represents a ‘real world’ medi-
Table 7. Primary endpoint of obtaining an electrocardiogram in total 
sample
Baseline characteristics AOR 95% CI P-value
RFV Seizure 1.61 1.35–1.93 0.001
Syncope 10.86 8.52–13.84 0.001
Age (yr) 0-17 Ref Ref Ref
18-44 5.37 4.73–6.11 0.001
45-64 13.21 11.55–15.11 0.001
≥65 22.13 19.10–25.65 0.001
Race White Ref Ref Ref
Non-white 1.08 1.01–1.17 0.032
Arrival EMS 2.35 2.21–2.49 0.001
Insurance Self-pay Ref Ref Ref
Private insurance 1.24 1.16–1.31 0.001
Medicaid 1.03 0.96–1.10 0.438
Medicare 1.25 1.17–1.34 0.001
AOR, adjusted odds ratio; CI, confidence interval; RFV, reason for visit; EMS, emer-
gency medical service.
Table 6. Primary endpoint of obtaining an electrocardiogram in seizure 
versus syncope
Age group Seizure (%)  95% CI Syncope (%) 95% CI P-value
0-17 7.5 5.1–10.9 55.9 45.6–65.8 0.001
18-44 27.0 22.2–32.6 59.6 52.5–66.3 0.001
45-64 40.9 34.0–48.1 82.2 76.4–86.8 0.001
≥65 68.3 55.6–78.7 85.3 80.6–89.1 0.011
CI, confidence interval.
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cine representation of the treating providers diagnosis, after eval-
uation and testing is performed. This is different than the reason 
for visit, which is listed and abstracted from the chart as the ‘chief 
complaint.’ The change in reason for visit to final diagnosis is a 
reflection of what often occurs after initial evaluation. 
 In conclusion, patients evaluated in the ED for syncope received 
an ECG and cardiac biomarkers more frequently than those that 
had seizure. Patients presenting with seizure had a different final 
diagnosis approximately half the time, suggesting the need to do 
further testing to determine etiology of the event.
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